Trial Profile
Efficacy and tolerability of solifenacin and tamsulosin in patients with benign prostatic hyperplasia and overactive bladder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Aug 2013
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary) ; Tamsulosin (Primary)
- Indications Benign prostatic hyperplasia; Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- 30 Aug 2013 Results presented at the 43rd Annual Meeting of the International Continence Society.
- 30 Aug 2013 New trial record